Finance

Lists
Why is RAC up 2.91%?
Dive Deeper
RAC:ASX
Racura Oncology Ltd
A$1.59
+2.91%
(+0.045) 1D
Oct 20, 4:10:24 PM GMT+11  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for RAC...
Open
A$1.56
High
A$1.59
Low
A$1.53
Mkt. cap
310.74M
Avg. vol.
82.47K
Volume
24.67K
52-wk high
A$4.47
52-wk low
A$1.53
EPS
-A$0.06
Shares outstanding
196.07M
Open
A$1.56
High
A$1.59
Low
A$1.53
Mkt. cap
310.74M
Avg. vol.
82.47K
Volume
24.67K
52-wk high
A$4.47
52-wk low
A$1.53
EPS
-A$0.06
Shares outstanding
196.07M
News stories
From web sources and news partners
About Racura Oncology Ltd
CEODaniel Tillett
Employees-
Founded2011
Headquarters-
SectorBiotechnology
Websiteracuraoncology.com
Last report
Jan 29, 2026
Fiscal period
Q2 2026
- / -
Revenue / Est. (AUD)
1.41M / -
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.41M
1.41M
-
-
Cost of goods sold
127.77K
127.77K
417.22K
417.22K
Cost of revenue
127.77K
127.77K
417.22K
417.22K
Research and development expenses
1.72M
1.72M
2.09M
2.09M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
507.80K
507.80K
1.13M
1.13M
Operating expense
2.84M
2.84M
3.23M
3.23M
Total operating expenses
2.96M
2.96M
3.64M
3.64M
Operating income
-1.56M
-1.56M
-3.64M
-3.64M
Other non operating income
-42.62K
-42.62K
-37.35K
-37.35K
EBT including unusual items
-2.05M
-2.05M
-3.49M
-3.49M
EBT excluding unusual items
-1.48M
-1.48M
-3.49M
-3.49M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
175.95K
175.95K
294.96K
294.96K
Net income
-2.05M
-2.05M
-3.49M
-3.49M
Net profit margin
-145.81%
-145.81%
-
-
Earnings per share
-
-
-
-
Interest and investment income
119.85K
119.85K
186.80K
186.80K
Interest expense
-
-
-
-
Net interest expenses
119.85K
119.85K
186.80K
186.80K
Depreciation and amortization charges
70.30K
70.30K
70.30K
70.30K
EBITDA
-1.49M
-1.49M
-3.57M
-3.57M
Gain or loss from assets sale
-
-
-266.00
-266.00
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps